Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

18 trials with published results (7%)

Research Maturity

96 completed trials (37% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.6%

12 terminated out of 259 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

22%

58 trials in Phase 3/4

Results Transparency

19%

18 of 96 completed with results

Key Signals

18 with results89% success12 terminated

Data Visualizations

Phase Distribution

164Total
Not Applicable (93)
Early P 1 (1)
P 1 (2)
P 2 (10)
P 3 (13)
P 4 (45)

Trial Status

Completed96
Unknown74
Recruiting44
Not Yet Recruiting15
Terminated12
Active Not Recruiting8

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 96 completed trials

Clinical Trials (259)

Showing 20 of 20 trials
NCT07566403Not Yet Recruiting

Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.

NCT07563231Not Yet Recruiting

ABLUMINUS NP Polymer Free Sirolimus-Eluting Stent Registry at Geneva University Hospitals (ABLUMINUS-GVA)

NCT04876222Not ApplicableTerminated

Direct or Subacute Coronary Angiography in Patients With Out of Hospital Cardiac Arrest Without Coma.

NCT04938661Not ApplicableCompleted

Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)

NCT07544459Not ApplicableCompleted

Mindfulness-based Stress Reduction Combined With Aerobic Training in Cardiac Rehabilitation After Percutaneous Coronary Intervention: A Dual Impact on Kinesiophobia and Heart Rate Variability

NCT07539324Not ApplicableNot Yet Recruiting

Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD

NCT03852082Active Not Recruiting

Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention

NCT06909565Phase 4RecruitingPrimary

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

NCT07469397Recruiting

Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients

NCT05893498Not ApplicableActive Not RecruitingPrimary

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

NCT07446023Not ApplicableRecruitingPrimary

IVUS-FFR Accuracy for Coronary Stenosis

NCT06075368Active Not Recruiting

Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)

NCT07398001Not ApplicableNot Yet RecruitingPrimary

Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment

NCT03981835Completed

Management of Antiplatelet Regimen During Surgical Procedures

NCT03476369Phase 4TerminatedPrimary

Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention

NCT07383155Phase 4Not Yet RecruitingPrimary

Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes

NCT07378163Recruiting

Study on the Preferences for PCI Implantation Devices Among Doctors and Patients

NCT07378137Recruiting

Comparing the Components of Composite Endpoints for Healthcare Providers and Patients

NCT04654052Phase 4Active Not Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

NCT06143709Active Not Recruiting

Precision PCI Registry

Scroll to load more

Research Network

Activity Timeline